Divalproex Sodium
Product Images NDC 71610-311

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71610-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 500 mg (71610 0311 53)

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

10 (Divalproex Sodium Extended Release Tablets Usp 1)

FDA Label Image

Figure 1 (Divalproex Sodium Extended Release Tablets Usp 2)

FDA Label Image

Figure 2 (Divalproex Sodium Extended Release Tablets Usp 3)

Figure 2 (Divalproex Sodium Extended Release Tablets Usp 3)
The text describes a chart showing the reduction in CPS rate with high and low doses of Divalproex Sodium. It displays the improvement, no change, and worsening of the condition in terms of percentage of patients.*
FDA Label Image

Figure 3 (Divalproex Sodium Extended Release Tablets Usp 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.